Literature DB >> 19298794

hnRNP L binds to CA repeats in the 3'UTR of bcl-2 mRNA.

Dong-Hyoung Lee1, Mi-Hyun Lim, Dong-Ye Youn, Seung Eun Jung, Young Soo Ahn, Yoshihide Tsujimoto, Jeong-Hwa Lee.   

Abstract

We previously reported that the CA-repeat sequence in the 3'-untranslated region (3'UTR) of bcl-2 mRNA is involved in the decay of bcl-2 mRNA. However, the trans-acting factor for the CA element in bcl-2 mRNA remains unidentified. The heterogeneous nuclear ribonucleoprotein L (hnRNP L), an intron splicing factor, has been reported to bind to CA repeats and CA clusters in the 3'UTR of several genes. We reported herein that the CA repeats of bcl-2 mRNA have the potential to form a distinct ribonuclear protein complex in cytoplasmic extracts of MCF-7 cells, as evidenced by RNA electrophoretic mobility shift assays (REMSA). A super-shift assay using the hnRNP L antibody completely shifted the complex. Immunoprecipitation with the hnRNP L antibody and MCF-7 cells followed by RT-PCR revealed that hnRNP L interacts with endogenous bcl-2 mRNA in vivo. Furthermore, the suppression of hnRNP L in MCF-7 cells by the transfection of siRNA for hnRNP L resulted in a delay in the degradation of RNA transcripts including CA repeats of bcl-2 mRNA in vitro, suggesting that the interaction between hnRNPL and CA repeats of bcl-2 mRNA participates in destabilizing bcl-2 mRNA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19298794     DOI: 10.1016/j.bbrc.2009.03.069

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Nonsense-mediated mRNA decay: The challenge of telling right from wrong in a complex transcriptome.

Authors:  Aparna Kishor; Sarah E Fritz; J Robert Hogg
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-05-26       Impact factor: 9.957

2.  Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

Authors:  Teng Fei; Yiwen Chen; Tengfei Xiao; Wei Li; Laura Cato; Peng Zhang; Maura B Cotter; Michaela Bowden; Rosina T Lis; Shuang G Zhao; Qiu Wu; Felix Y Feng; Massimo Loda; Housheng Hansen He; X Shirley Liu; Myles Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-13       Impact factor: 11.205

3.  hnRNP L-dependent protection of normal mRNAs from NMD subverts quality control in B cell lymphoma.

Authors:  Aparna Kishor; Zhiyun Ge; J Robert Hogg
Journal:  EMBO J       Date:  2018-12-07       Impact factor: 11.598

4.  Effect of Modulation of hnRNP L Levels on the Decay of bcl-2 mRNA in MCF-7 Cells.

Authors:  Mi-Hyun Lim; Dong-Hyoung Lee; Seung Eun Jung; Dong-Ye Youn; Chan Sun Park; Jeong-Hwa Lee
Journal:  Korean J Physiol Pharmacol       Date:  2010-02-28       Impact factor: 2.016

5.  hnRNP L-mediated RNA switches function as a hypoxia-induced translational regulon.

Authors:  Kadiam C Venkata Subbaiah; Jiangbin Wu; Alka Potdar; Peng Yao
Journal:  Biochem Biophys Res Commun       Date:  2019-06-26       Impact factor: 3.575

6.  Crosslinking-immunoprecipitation (iCLIP) analysis reveals global regulatory roles of hnRNP L.

Authors:  Oliver Rossbach; Lee-Hsueh Hung; Ekaterina Khrameeva; Silke Schreiner; Julian König; Tomaž Curk; Blaž Zupan; Jernej Ule; Mikhail S Gelfand; Albrecht Bindereif
Journal:  RNA Biol       Date:  2014-02-07       Impact factor: 4.652

7.  Heterogeneous Nuclear Ribonucleoprotein L is required for the survival and functional integrity of murine hematopoietic stem cells.

Authors:  Marie-Claude Gaudreau; Damien Grapton; Anne Helness; Charles Vadnais; Jennifer Fraszczak; Peiman Shooshtarizadeh; Brian Wilhelm; François Robert; Florian Heyd; Tarik Möröy
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

8.  Cleavage and polyadenylation: Ending the message expands gene regulation.

Authors:  Jonathan Neve; Radhika Patel; Zhiqiao Wang; Alastair Louey; André Martin Furger
Journal:  RNA Biol       Date:  2017-04-28       Impact factor: 4.652

9.  HnRNP-L mediates bladder cancer progression by inhibiting apoptotic signaling and enhancing MAPK signaling pathways.

Authors:  Daojun Lv; Huayan Wu; Rongwei Xing; Fangpeng Shu; Bin Lei; Chengyong Lei; Xumin Zhou; Bo Wan; Yu Yang; Liren Zhong; Xiangming Mao; Yaguang Zou
Journal:  Oncotarget       Date:  2017-02-21

10.  The transcriptional complex between the BCL2 i-motif and hnRNP LL is a molecular switch for control of gene expression that can be modulated by small molecules.

Authors:  Hyun-Jin Kang; Samantha Kendrick; Sidney M Hecht; Laurence H Hurley
Journal:  J Am Chem Soc       Date:  2014-03-07       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.